Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016722
Filing Date
2022-11-08
Accepted
2022-11-08 06:30:35
Documents
68
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ispc-20220930x10q.htm   iXBRL 10-Q 1936960
2 EX-31.1 ispc-20220930xex31d1.htm EX-31.1 17040
3 EX-31.2 ispc-20220930xex31d2.htm EX-31.2 16625
4 EX-32.1 ispc-20220930xex32d1.htm EX-32.1 6934
  Complete submission text file 0001558370-22-016722.txt   6787014

Data Files

Seq Description Document Type Size
5 EX-101.SCH ispc-20220930.xsd EX-101.SCH 44249
6 EX-101.CAL ispc-20220930_cal.xml EX-101.CAL 50497
7 EX-101.DEF ispc-20220930_def.xml EX-101.DEF 174345
8 EX-101.LAB ispc-20220930_lab.xml EX-101.LAB 435945
9 EX-101.PRE ispc-20220930_pre.xml EX-101.PRE 331504
62 EXTRACTED XBRL INSTANCE DOCUMENT ispc-20220930x10q_htm.xml XML 1017543
Mailing Address 450 BEDFORD STREET SUITE 1010 LEXINGTON MA 02420
Business Address 450 BEDFORD STREET SUITE 1010 LEXINGTON MA 02420 781-301-6700
iSpecimen Inc. (Filer) CIK: 0001558569 (see all company filings)

EIN.: 270480143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40501 | Film No.: 221367122
SIC: 8731 Services-Commercial Physical & Biological Research